Drug-drug interactions in a cohort of hospitalized elderly patients

Pharmacoepidemiology and Drug Safety

Volumn 22, Issue 10, 2013, Pages 1054-1060

  Pasina, Luca ^a   Djade, Codjo D ^a   Nobili, Alessandro ^a   Tettamanti, Mauro ^a   Franchi, Carlotta ^a   Salerno, Francesco ^b   Corrao, Salvatore ^c   Marengoni, Alessandra ^d   Iorio, Alfonso ^e   Marcucci, Maura ^e   Mannucci, Piermannuccio ^f  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

^e UNIVERSITY OF PERUGIA   (Italy)

^f FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Aged; Drug interactions; Hospitalization; Mortality; Pharmacoepidemiology

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; AMIODARONE; AMLODIPINE; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM ANTAGONIST; CLOPIDOGREL; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ESOMEPRAZOLE; FUROSEMIDE; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LANSOPRAZOLE; POTASSIUM; POTASSIUM SPARING DIURETIC AGENT; PROTON PUMP INHIBITOR; SIMVASTATIN; SPIRONOLACTONE; TICLOPIDINE; VERAPAMIL;

AGED; ALLERGIC REACTION; ARTICLE; BLEEDING; BRADYCARDIA; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIGITALIS INTOXICATION; DRUG DRUG INTERACTION; DRUG EFFICACY; DRUG INTERACTION; FEMALE; FOLLOW UP; HEART ARREST; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; HYPERKALEMIA; HYPOTENSION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MYOPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RASH; RHABDOMYOLYSIS; STEVENS JOHNSON SYNDROME; THROMBOSIS;

AGED; DRUG INTERACTIONS; HOSPITALIZATION; MORTALITY; PHARMACOEPIDEMIOLOGY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DRUG INTERACTIONS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HOSPITALIZATION; HUMANS; ITALY; MALE; MULTIVARIATE ANALYSIS; POLYPHARMACY;

EID: 84885022103     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3510     Document Type: Article

References (35)

1. Moura CS, Acurcio FA, Belo NO. Drug-drug interactions associated with length of stay and cost of hospitalization. J Pharm Pharm Sci 2009; 12(3): 266-272
2. Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011; 365(21): 2002-2012.
3. Hilmer SN, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther 2009; 85: 86-98.
4. Steinman MA, Landefeld CS, Rosenthal GE, et al. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 2006; 54: 1516-1523.
5. Koh Y, Kutty FBM, Li SC. Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender. Ther Clin Risk Manag 2005; 1: 39-48.
6. Lund BC, Carnahan RM, Egge JA, Chrischilles EA, Kaboli PJ. Inappropriate prescribing predicts adverse drug events in older adults. Ann Pharmacother 2010; 44(6): 957-963.
7. Nobili A, Garattini S, Mannucci PM. Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium. Journal of Comorbidity 2011; 1: 28-44.
8. Cruciol-Souza JM, Thomson, JC. Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital. J Pharm Pharm Sci 2006; 9: 427-433.
9. Egger SS, Ratz AE, Bravo AE, Hess L, Schlienger RG, Krahenbuhl S. Age-related differences in the prevalence of potential drug-drug interactions in ambulatory dyslipidaemic patients treated with statins. Drugs Aging, 2007; 24: 429-440.
10. Gagne JJ, Maio V, Rabinowitz C. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy. J Clin Pharm Ther 2008; 33: 141-151.
11. Radosevic N, Gantumur M, Vlahovic-Palcevski V. Potentially inappropriate prescribing to hospitalised patients. Pharmacoepidemiol Drug Saf 2008; 17: 733-737.
12. Lin CF, Wang CY, Bai, CH. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan. Drugs Aging 2011; 28(3): 219-225.
13. Hines LE, Murphy JE. Potentially harmful drug-drug interactions in the elderly: a review. Am J Geriatr Pharmacother 2011; 9(6): 364-377
14. Klotz U Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev 2009; 41: 67-76.
15. Bowie MW, Slattum PW. Pharmacodynamics in older adults: a review. Am J Geriatr Pharmacother 2007; 5: 263-303.
16. Cusack BJ. Pharmacokinetics in older persons. Am J Geriatr Pharmacother 2004; (4): 274-302. Review.
17. Kinirons MT, O'Mahony MS. Drug metabolism and ageing. Br J Clin Pharmacol 2004; 57(5): 540-544. Review
18. Hastings SN, Schmader KE, Sloane RJ, et al. Quality of pharmacotherapy and outcomes for older veterans discharged from the emergency department. J Am Geriatr Soc 2008; 56: 875-880.
19. Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600, 000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf. 2007; 30(10): 911-918.
20. Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 2008;300:2867-2878.
21. Vonbach P, Dubied A, Krahenbuhl S, Beer JH. Prevalence of drug-drug interactions at hospital entry and during hospital stay of patients in internal medicine. Eur J Intern Med 2008; 19: 413-420.
22. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329(7456): 15-19.
23. Becker ML, Kallewaard M, Caspers PW, Visser LE, Leufkens HG, Stricker BH. Hospitalisations and emergency department visits due to drug-drug interactions: a literature review. Pharmacoepidemiol Drug Saf 2007; 16: 641-651.
24. Espinosa-Bosch M, Santos-Ramos B, Gil-Navarro MV, Santos-Rubio MD, Marín-Gil R, Villacorta-Linaza P. Prevalence of drug interactions in hospital healthcare. Int J Clin Pharm 2012; 34(6): 807-817.
25. Parmelee PA, Thuras PD, Katz IR, Lawton MP. Validation of the Cumulative Illness Rating Scale in a geriatric residential population. J Am Geriatr Soc 1995; 43(2): 130-137.
26. Shah S, Vanclay F, Cooper B. Improving the sensitivity of the Barthel Index for stroke rehabilitation. J Clin Epidemiol 1989; 42(8): 703-709.
27. Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry 1983; 140(6): 734-739.
28. Hickie C, Snowdon J. Depression scales for the elderly: GDS, Gilleard, Zung. Clin. Gerontologist 1987; 6(3): 51-53.
29. Nobili A, Pasina L, Tettamanti M, Lucca U, Riva E, Marzona I, Monesi L, Cucchiani R, Bortolotti A, Fortino I, Merlino L, Walter Locatelli G, Giuliani G. Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database. J Clin Pharm Ther 2009; 34(4): 377-386.
30. Egger SS, Drewe J, Schlienger RG. Potential drug-drug interactions in the medication of medical patients at hospital discharge. Eur J Clin Pharmacol 2003; 58(11): 773-778.
31. Leone R, Magro L, Moretti U, et al. Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy. Drug Saf 2010; 1;33(8): 667-675.
32. Kalyanasundaram A, Lincoff AM. Managing adverse effects and drug-drug interactions of antiplatelet agents. Nat Rev Cardiol 2011; 8(10): 592-600.
33. Juurlink DN, Mamdani M, Kopp A, Laupacis A, Redelmeier DA. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003; 289(13): 1652-1658.
34. Juurlink DN, Gomes T, Ko DT, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ 2009 31;180(7): 713-718.
35. Cuisset T, Frere C, Quilici J, et al. Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (proton pump inhibitors and clopidogrel association) prospective randomized study. J Am Coll Cardiol 2009; 22;54(13): 1149-1153.